The “smart pills” market, which generated $600M revenue in 2023, is poised to reach $1.1B by 2028, growing at a CAGR of 11.8% from 2023 to 2028, according to a MarketsandMarkets™ report. “Smart pills” will enable remote patient monitoring, providing real-time data on physiological parameters and medication adherence. With imaging capabilities, they will enhance diagnostics by capturing detailed images and videos of the gastrointestinal tract.
Moreover, smart pills will enable targeted drug delivery, releasing medications at specific locations within the body. Personalized medicine will be a key focus, as smart pills gather individualized health data to tailor treatment plans and lifestyle recommendations. However, addressing data privacy and security concerns, as well as navigating regulatory challenges, will be imperative for the industry's success.